News

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 ...
PharmiWeb3d
Applied DNA's LineaRx Subsidiary Stands Ready to S…
Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), ...
Morningstar4d
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
The LineaIVT platform combines DNA IVT template manufacturing via the LineaDNA platform with a proprietary RNA polymerase, LineaRNAP™, to enable mRNA and sa-mRNA manufacturers to produce what ...
drugtargetreview.com3d
Guide: Create DNA Template for In Vitro mRNA Synthesis
Learn how to simplify the entire DNA template generation workflow, streamlining mRNA therapeutic research. Successful in vitro transcription (IVT) and translation for therapeutic applications require ...
Investing4d
Applied DNA secures U.S. supply chain for key materials
The platform’s recent advancements include the LineaIVT platform, which integrates DNA IVT template manufacturing with a proprietary RNA polymerase, LineaRNAP™, to produce mRNA therapeutics ...
Investing3d
Applied DNA secures U.S. supply chain for key materials
The platform’s recent advancements include the LineaIVT platform, which integrates DNA IVT template manufacturing with a proprietary RNA polymerase, LineaRNAP™, to produce mRNA therapeutics more ...
Yahoo Finance1d
Applied DNA Sciences, Inc. (APDN)
Co-Hosts Seminar with mRNA CDMO Kudo Bio to Demonstrate Linea IVT Capability for Rapid mRNA Manufacturing - STONY BROOK, NY / ACCESSWIRE / September 17, 2024 /Applied DNA Sciences, Inc. (NASDAQ ...